Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CDK4 | P11802 | 1/20 | 0.46 |
| ▸ | CCND1 | P24385 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | RXRG | P48443 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30342568 | 1.00 | ALDH1A1 (0.57) | ALDH1A1FFAR4IDO1NPC1RAB9A | |
| SCHEMBL18171756 | 0.86 | ALDH1A1 (0.66) | ALDH1A1FFAR4IDO1NPC1RAB9A | |
| SCHEMBL22138645 | 0.86 | CDK4 (0.53) | ALDH1A1NPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL3521430 | 0.84 | CDK4 (0.60) | ALDH1A1NPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL2290442 | 0.83 | FFAR4 (0.50) | ALDH1A1FFAR4IDO1NPC1RAB9A | |
| SCHEMBL2288552 | 0.83 | FFAR4 (0.60) | ALDH1A1FFAR4IDO1NPC1RAB9A | |
| SCHEMBL30023195 | 0.83 | FFAR4 (0.60) | ALDH1A1FFAR4IDO1NPC1RAB9A | |
| SCHEMBL30000324 | 0.83 | FFAR4 (0.50) | ALDH1A1FFAR4IDO1NPC1RAB9A | |
| Bromide SCHEMBL27650271 | 0.82 | CDK4 (0.58) | ALDH1A1NPC1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL2290933 | 0.81 | IDO1 (0.50) | ALDH1A1FFAR4IDO1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112409206-A | Preparation method of kresoxim-methyl | 新发药业有限公司 | 2021-02-26 | — | — | CN | disclosed |
| EP-2149545-B1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2016-10-05 | — | — | EP | disclosed |
| US-7994367-B2 | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2149545-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-02-03 | — | — | EP | disclosed |
| US-6177459-B1 | WELL TOLERATED BY PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0741693-B1 | PROCESS FOR THE PREPARATION OF ARYLACETIC ESTER DERIVATIVES VIA PALLADIUM-CATALYZED CROSS COUPLING REACTION | NOVARTIS AG (CH) | 1999-03-24 | — | — | EP | disclosed |
| EP-0712835-B1 | Process for the preparation of alpha-ketocarbonic acid esters | BASF AG (DE) | 1997-08-20 | — | — | EP | disclosed |
| EP-0741693-A1 | PROCESS FOR THE PREPARATION OF ARYLACETIC ESTER DERIVATIVES VIA PALLADIUM-CATALYZED CROSS COUPLING REACTION | Novartis AG (CH) | 1996-11-13 | — | — | EP | disclosed |
| US-5573999-A | FUNGICIDES AND INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-12 | — | — | US | disclosed |
| EP-0493711-B1 | Process for the preparation of E-oximethers from phenylglyoxylic acid esters | BASF AG (DE) | 1996-09-25 | — | — | EP | disclosed |
| US-5538940-A | FUNGICIDE, MITICIDE, INSECTICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-23 | — | — | US | disclosed |
| EP-0712835-A2 | Process for the preparation of alpha-ketocarbonic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 1996-05-22 | — | — | EP | disclosed |
| EP-0525516-B1 | Derivatives of beta substituted cinnomic acid | BASF AG (DE) | 1995-09-27 | — | — | EP | disclosed |
| WO-1995020569-A1 | PROCESS FOR THE PREPARATION OF ARYLACETIC ESTER DERIVATIVES VIA PALLADIUM-CATALYZED CROSS COUPLING REACTION | CIBA-GEIGY AG (CH) | 1995-08-03 | — | — | WO | disclosed |
| US-5221762-A | Reacting a phenol with benzolactone compound; then phosgene or thionyl chloride; esterification with alcohol | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-22 | — | — | US | disclosed |
| EP-0525516-A2 | Derivatives of beta substituted cinnomic acid | BASF Aktiengesellschaft (DE) | 1993-02-03 | — | — | EP | disclosed |
| EP-0493711-A1 | Process for the preparation of E-oximethers from phenylglyoxylic acid esters | BASF Aktiengesellschaft (DE) | 1992-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | NQO1, C9, TRPA1 | ALDH1A1 83/4885FFAR4 3092/4885IDO1 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.